Advertisement

Topics

Companies Related to "A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men" [Most Relevant Company Matches] RSS

01:59 EST 16th December 2018 | BioPortfolio

Here are the most relevant search results for "A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men" found in our extensive corporate database of over 50,000 company records.

Showing "Drug Interaction Study Valproic Acid Single dose Paliperidone" Companies 1–25 of 5,000+

Relevant

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.


PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

Bio-Path Holdings, Inc.

Bio-Path is developing a patented, liposomal drug delivery system and products developed at The University of Texas M. D. Anderson Cancer Center, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development.


International Society for the Study of Xenobiotics

Man's use of xenobiotics dates from antiquity but interest in foreign compound metabolism dates from only the mid-19th century when the knowledge and techniques of organic chemistry were first applied to its study. For nearly a century thereafter biotransformation was generally equated with "detoxication" or the elimination of a compound's biological activity.This view changed in the late 1930s wi...

Bespak Europe

Bespak, founded more than 40 years ago, has established a reputation as a leading supplier of drug delivery technologies and services to the pharmaceutical and biotechnology industries.The company’s comprehensive capabilities have enabled it to develop proprietary drug delivery devices and technologies, many protected by worldwide patents. These include pressurised metered dose inhalers and actu...

Ameritox

The single-group, multi-dose study examined the ability of the Rx Guardian(SM) algorithm to differentiate among low, medium and high daily doses of OxyContin®. Oxycodone levels were detected in the urine of 36 healthy volunteers using a liquid chromatography-mass spectrometry (LC-MS-MS) assay. Participants were randomized to receive 80mg, 160mg or 240mg of daily OxyContin® to steady state cond...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Berzelius Clinical Research Center

Berzelius Clinical Research Center AB (BCRC) is a unique Site Management Organisation specialised in clinical conduct of Phase 0/I/II studies and the ideal partner for Contract Research Organisations (CRO) and pharmaceutical companies. BCRC has a hospital based well-equipped clinical pharmacology unit. Having a fully trained critical care staff enables easy setup of invasive techniques and procedu...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

Privia

A clinical trial is a research study. Research studies are used to decide how treatments work and how safe they are. While in a study, a person may receive either an investigational drug, a marketed drug, a placebo, or a combination of these. An investigational drug is one that is nor approved by the Food and Drug Administration, a marketed drug is FDA approved and a placebo is like a "sugar pill"...

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is a specialty pharmaceuticals company with an experienced team of experts in drug development focusing its efforts on the clinical development of new therapies for dyslipidemia. The lead product candidate is Epanova™, an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic ...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Spaulding Clinical

Spaulding Clinical (www.spauldingclinical.com) is a Phase 1 Clinical Pharmacology Research Unit and Electrocardiography Core Lab located in West Bend, Wisconsin offering a full range of services. The company has extensive experience conducting TQT studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, a...

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...

Annovis

Annovis, Inc. (Annovis) is a specialty chemicals company that is focused on staking out a leading position in the "mimetics" field. Mimetics are chemically modified biomolecules that, by virtue of such modifications, have the potential to enhance drug function. Operating from an established platform of nucleic acid research, Annovis has entered a number of collaborations with pharmaceutical and di...

Mission Bio, Inc.

Mission Bio, Inc. is innovating technologies to analyze single cells within complex biological systems, revealing critical information not observable from bulk sample analysis. With proprietary microfluidic droplet technology, Mission Bio is developing research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of ...

PediaCare

Dr. David Hill, father, pediatrician and author of “Dad to Dad: Parenting like a Pro,” partnered with PediaCare® to introduce a new single dose children’s medicine product. (Photo: Business Wire)

RWTH Aachen University

RWTH Aachen University,Here, you will discover numerous opportunities offered at this university in the areas of research, teaching and study.The RWTH Aachen is characterised by its strength in science and engineering education. It also provides a wide range of subjects in Economics, Arts and Humanities and Medicine with an emphasis on intensive interaction between all disciplines. The focus on in...

Q-RNA, Inc.

Q-RNA, Inc., was founded in 1996 by Abraham Grossman, Ph.D., a molecular biologist with both academic and industry experience. The early efforts of Q-RNA were focused on the development of RNA (ribonucleic acid) ligands and their interaction with proteins. Recent discoveries have put Q-RNA in the forefront of opening the secrets to a vast number of protein misfolding disorders representing major u...

Donboo Amino Acid Co., Ltd

Donboo Amino Acid Co., Ltd is an enterprise with advanced science and technology. We specialize in scientific research, manufacture & trade of amino acids and its derivations. It is over 10 years since we were devoted to the scientific research and development of amino acid. We have now established friendly trade contacts with many amino acid factories throughout the P.R.China. With a fully-ranged...

Hemispherx Biopharma

Hemispherx Biopharma, Inc. has devoted nearly three decades to exploring, understanding, and mastering the mechanism of RNA technology. The Company's longevity as a biomedical research and drug development institution, coupled with its record of tremendous enduring scientific achievement is evidence of Hemispherx’s long-term commitment to this promising new class of drugs and to bring new therap...

Credence MedSystems, Inc.

Credence MedSystems is a medical technology and specialty pharmaceutical company focused on delivering medications safely for the benefit of our patients, caregivers and partners. The Credence Companion Safety Syringe System combines passive retractable needle safety with a modular approach that leaves the primary drug container unchanged, a major advantag...

Advanced Biomedical Research Incorporated

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in Pennington, New Jersey adjacent to the Princeton biopharmaceutical research corridor. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

Entropin

Entropin, Inc. (NASDAQ: ETOP) is a specialty pharmaceutical development company focused on commercializing Esterom®, a revolutionary new topical drug with the potential to replace other current therapeutics for treating impaired physical function resulting from painful soft tissue injuries and diseases -- such as tendonitis, bursitis and lower back sprain. The Esterom® market is currently served...


More From BioPortfolio on "A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks